Dr. Ruffolo has been responsible for the discovery and development of several marketed products over the course of his career in the pharmaceutical industry. He is the former President of Research and Development for Wyeth Pharmaceuticals, managing a research and development organization of 9,000 scientists with an annual budget in excess of $3 billion. Before joining Wyeth, Dr. Ruffolo spent 17 years at SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline), where he was Senior Vice President and Director of Biological Sciences, Worldwide. Dr. Ruffolo received both a Ph.D. in pharmacology and a B.S. from The Ohio State University. Dr. Ruffolo has received numerous awards including the 2008 Scrip Lifetime Achievement Award and the 2008 Discoverer’s Award for the discovery and development of Coreg (carvedilol) for the treatment of congestive heart failure.